Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8BG30

Entry ID Method Resolution Chain Position Source
AF-Q8BG30-F1 Predicted AlphaFoldDB

26 variants for Q8BG30

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388755373 2 A>T No EVA
rs3388755309 24 W>* No EVA
rs3388747428 24 W>R No EVA
rs3388751188 28 S>I No EVA
rs3388755741 44 C>* No EVA
rs3388737989 64 P>T No EVA
rs3395396562 69 D>H No EVA
rs3388747463 80 Q>R No EVA
rs3388749850 114 N>I No EVA
rs3388747817 123 E>D No EVA
rs3388755701 124 L>H No EVA
rs3388751217 129 S>N No EVA
rs3388747424 145 N>S No EVA
rs3388747435 180 Q>* No EVA
rs3388740614 300 Y>F No EVA
rs3388752250 310 L>H No EVA
rs3388755792 318 T>I No EVA
rs3388761020 329 P>T No EVA
rs3388751244 336 S>F No EVA
rs3388747443 339 P>S No EVA
rs3388751219 372 Q>H No EVA
rs3388752264 400 P>L No EVA
rs3388754968 437 R>G No EVA
rs3388744668 452 K>E No EVA
rs3388755780 470 E>K No EVA
rs3388747446 502 M>I No EVA

No associated diseases with Q8BG30

1 regional properties for Q8BG30

Type Name Position InterPro Accession
domain Hepatitis delta antigen (HDAg) domain 89 - 248 IPR037517

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
NELF complex A complex of five proteins, designated NELF-A, -B, -C, -D, and -E in human, that can physically associate with RNP polymerase II to induce transcriptional pausing.
nuclear body Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

2 GO annotations of molecular function

Name Definition
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
molecular adaptor activity The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.

3 GO annotations of biological process

Name Definition
negative regulation of transcription elongation by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
positive regulation of histone H3-K4 methylation Any process that activates or increases the frequency, rate or extent of the covalent addition of a methyl group to the lysine at position 4 of histone H3.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9H3P2 NELFA Negative elongation factor A Homo sapiens (Human) PR
10 20 30 40 50 60
MASMRESDTG LWLHNKLGAT DELWAPPSIA SLLTAAVIDN IRLCFHRLSS AVKLKLLLGT
70 80 90 100 110 120
LHLPRRTVDE MKAALMDIIQ LATLDSDPWV LMVADILKSF PDTGSLNLDL EEQNPNVQDI
130 140 150 160 170 180
LGELREKVSE CEASAMLPLE CQYLNKNALT TLAGPLTPPV KHFQLKRKPK SATLRAELLQ
190 200 210 220 230 240
KSTETAQQLK RSAGVPFHAK GRGLLRKMDT TTPLKGIPKQ APFRSPTTPS VFSPSGNRTP
250 260 270 280 290 300
IPPSRTPLQK ERGVKLLDIS ELNTVGAGRE AKRRRKTLDT EVVEKPTKEE TVVENATPDY
310 320 330 340 350 360
AAGLVSTQKL GSLNSEPTLP STSYLPSTPS VVPASSYIPS SETPPAPPSR EASRPPEEPS
370 380 390 400 410 420
APSPTLPTQF KQRAPMYNSG LSPATPAPAA PTSPLTPTTP PAVTPTAQTP PVAMVAPQTQ
430 440 450 460 470 480
APAPVQQQPK KNLSLTREQM FAAQEMFKTA NKVTRPEKAL ILGFMAGSRE NPCPEQGDVI
490 500 510 520
QIKLSEHTED LPKADGQGST TMLVDTVFEM NYATGQWTRF KKYKPMTNVS